Transplant Cell Ther. 2023 Dec;29(12):727-729. doi: 10.1016/j.jtct.2023.11.004.
NO ABSTRACT
PMID:38035888 | DOI:10.1016/j.jtct.2023.11.004
Recent Content
- Breaking Down Barriers to Diagnosis in AYA Patients With Lymphoma
- Breaking New Ground: Emerging Therapies for Treatment of EGFR-Positive NSCLC
- Vitamin B Supplements Could Aid Glaucoma, Slowing Disease Progression
- FDA Approves Avutometinib/Defactinib for Adults With KRAS-Mutated Recurrent LGSOC
- Obicetrapib Plus Ezetimibe Reduced LDL-C in Patients With or at Risk of Atherosclerotic Cardiovascular Disease
- NCPA: Any Pharma Tariffs Should Be Tailored to Avoid Increasing Shortages and Costs
- Biomarker Testing Remains Crucial for Young Patients With Lung Cancer
- How Cancer Care Teams Can Help With the Cessation of Smoking
- Asembia AXS25: Navigating the Transformative Landscape of GLP-1 Medications
- The Role of Physical Activity in Breast Cancer Risk Reduction and Survival